Laboratory News and Research

RSS

New molecule shows potential therapeutic effects against arthritis

Arthritis affects almost 2% of the world's population, or some 150 million people, and currently, there is no completely effective treatment for this chronic disease. A new molecule developed in the laboratory has been shown to have potential therapeutic effects.

12 Aug 2020

Swapping out red meat for plant-based meat alternatives lowers cardiovascular risk

Now, a new study by researchers at Stanford University School of Medicine has revealed that swapping out red meat for certain plant-based meat alternatives can help improve some cardiovascular risk factors. The use of plant-based alternative meats, there is still limited evidence of the health effects of these products.

12 Aug 2020

New technology could serve as more reliable model of amyotrophic lateral sclerosis

A new study published today demonstrates that a technology developed at the University of Central Florida could serve as a more reliable clinically-based model of amyotrophic lateral sclerosis (ALS) and a better screening tool for novel therapies than currently use preclinical models.

12 Aug 2020

WVU toxicologist wins NIH grant to study impact of air pollution on lung tissue regeneration

Each time we breathe in, we're not inhaling just one component that seeps into our lungs. It's a medley of gasses and particles - both natural and human-made - that can unleash unknown consequences on respiratory health.

11 Aug 2020

Fluorescent molecules in urine can help monitor malignant melanoma

What if you could simply provide a urine sample rather than undergo a painful surgical procedure to find out if your cancer was responding to treatment? It may seem too good to be true, but researchers at Pavol Jozef Šafárik University in Košice, Slovakia, have identified fluorescent molecules in urine that may allow patients with malignant melanoma to do just that.

11 Aug 2020

Inhaled delivery of a potent neutralizing nanobody effective against SARS-CoV-2

A recent study by researchers from China, available on the bioRxiv preprint server, shows how stable neutralizing nanobody Nb11-59 might be a promising prophylactic and therapeutic molecule against coronavirus disease (COVID-19) – especially if administered via the inhalatory route.

11 Aug 2020

Stanford study reveals immunological deviations and lapses in severe COVID-19 cases

Some people get really sick from COVID-19, and others don't. Nobody knows why.

11 Aug 2020

Certain N95 masks are highly effective in preventing the inhalation of airborne particles

This spring, due to limited national supplies of N95 face masks, hospitals across the country asked the public and private companies to donate personal protective equipment (PPE), including many different types of masks, to be sure healthcare workers were protected while caring for patients.

11 Aug 2020

Researchers review South Korean health policy towards COVID-19

As the world continues to closely monitor the newest coronavirus outbreak, the government of South Korea has been able to keep the disease under control without paralyzing the national health and economic systems.

11 Aug 2020

SARS-CoV-2 infection and transmission possible in North American deer mice

The current COVID-19 pandemic began as a zoonosis in China, at the end of 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel betacoronavirus with significant similarity to an earlier virus of the same family.

11 Aug 2020

COVID-19 Prevention Network announces Phase 3 trials to evaluate monoclonal antibodies

The COVID-19 Prevention Network (CoVPN) today announced two Phase 3 trials to determine whether monoclonal antibodies (mAbs) can prevent SARS-CoV-2, the virus that causes COVID-19.

11 Aug 2020

Oxygen-deprived breast cancer cells send out messages that promote cancer progression

According to a study by The Wistar Institute, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

11 Aug 2020

Finned nanoporous catalyst facilitates molecular transport

Thousands of chemical processes used by the energy industry and for other applications rely on the high speed of catalytic reactions, but molecules frequently are hindered by molecular traffic jams that slow them down.

10 Aug 2020

Persistent hiccups an unusual COVID-19 symptom

Now, a team of researchers revealed another atypical symptom reported by patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19) – persistent hiccups.

10 Aug 2020

NIH supports research on how pathogens evolve

For several years, physicist John Barton at the University of California, Riverside, has been working on developing models to understand and predict how pathogens, such as HIV, evolve. This research pursuit has just received support from the National Institutes of Health.

10 Aug 2020

Rice engineers use gene editing to facilitate drug discovery based on natural fungus

Rice University scientists have won federal support for their pursuit of novel drugs to treat human disease.

10 Aug 2020

Oxytocin can aid in the control and prevention of osteoporosis

Oxytocin, produced by the hypothalamus and sometimes known as the "love hormone" for its involvement in pair bonding and orgasm, can be a strong ally in the control and prevention of osteoporosis, according to a study by scientists at São Paulo State University in Brazil.

10 Aug 2020

CRISPR-based COVID-19 surveillance

A recent US study available on the medRxiv preprint server supports the use of self-collected oropharyngeal swabs, together with CRISPR- and PCR-based diagnostic assays, as rapid, feasible and reliable approach for the surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in university students and other asymptomatic individuals

10 Aug 2020

NIH awards $1.2 million grant to create humanized mice susceptible to COVID-19

The National Institutes of Health has awarded a grant of $1.2 million to the Mouse Biology Program at the University of California, Davis, to create mice that are susceptible to the COVID-19 virus, and to distribute them to researchers.

10 Aug 2020

Additional $400,000 awarded for research projects focused on cardiovascular impact of COVID-19

The American Heart Association has awarded an additional $400,000 in research grants focused on the cardiovascular impact of COVID-19.

10 Aug 2020

Laboratory News and Research

New molecule shows potential therapeutic effects against arthritis

Swapping out red meat for plant-based meat alternatives lowers cardiovascular risk

New technology could serve as more reliable model of amyotrophic lateral sclerosis

WVU toxicologist wins NIH grant to study impact of air pollution on lung tissue regeneration

Fluorescent molecules in urine can help monitor malignant melanoma

Inhaled delivery of a potent neutralizing nanobody effective against SARS-CoV-2

Stanford study reveals immunological deviations and lapses in severe COVID-19 cases

Certain N95 masks are highly effective in preventing the inhalation of airborne particles

Researchers review South Korean health policy towards COVID-19

SARS-CoV-2 infection and transmission possible in North American deer mice

COVID-19 Prevention Network announces Phase 3 trials to evaluate monoclonal antibodies

Oxygen-deprived breast cancer cells send out messages that promote cancer progression

Finned nanoporous catalyst facilitates molecular transport

Persistent hiccups an unusual COVID-19 symptom

NIH supports research on how pathogens evolve

Rice engineers use gene editing to facilitate drug discovery based on natural fungus

Oxytocin can aid in the control and prevention of osteoporosis

CRISPR-based COVID-19 surveillance

NIH awards $1.2 million grant to create humanized mice susceptible to COVID-19

Additional $400,000 awarded for research projects focused on cardiovascular impact of COVID-19

A guide to density measurement excellence eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo